Ending TB in Southeast Asia: current resources are not enough
The Southeast Asia Region continues to battle tuberculosis (TB) as one of its most severe health and development challenges. Unless there is a substantial increase in investments for TB prevention, diagnosis, care and treatment, there will be catastrophic effects for the region. The uncontrolled TB...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-03-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/5/3/e002073.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846127424100630528 |
|---|---|
| author | Vineet Bhatia Rahul Srivastava K Srikanth Reddy Mukta Sharma Partha Pratim Mandal Natasha Chhabra Shubhi Jhalani Sandip Mandal Nimalan Arinaminpathy Tjandra Yoga Aditama Swarup Sarkar |
| author_facet | Vineet Bhatia Rahul Srivastava K Srikanth Reddy Mukta Sharma Partha Pratim Mandal Natasha Chhabra Shubhi Jhalani Sandip Mandal Nimalan Arinaminpathy Tjandra Yoga Aditama Swarup Sarkar |
| author_sort | Vineet Bhatia |
| collection | DOAJ |
| description | The Southeast Asia Region continues to battle tuberculosis (TB) as one of its most severe health and development challenges. Unless there is a substantial increase in investments for TB prevention, diagnosis, care and treatment, there will be catastrophic effects for the region. The uncontrolled TB burden impacts socioeconomic development and increase of drug resistance in the region. Based on epidemiological inputs from a mathematical model, a costing analysis estimates that the desired targets of ending TB are achievable with additional interventions, and critical thresholds require an increase in spending by almost double the current levels. The data source for financial allocation to TB programmes is the report submitted by countries to WHO, while projections are based on modelling. The model accounts for funding needs for all strategies based on published data and accounts for programme and patient costs. This paper delineates the resource needs, availability and gaps of ending TB in the region. It is estimated that close to US$2 billion per year are needed in the region for TB-related activities for a meaningful bending of the incidence curve towards ending TB. |
| format | Article |
| id | doaj-art-01a11ccadcda4d4dbd6d640f55cec81a |
| institution | Kabale University |
| issn | 2059-7908 |
| language | English |
| publishDate | 2020-03-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Global Health |
| spelling | doaj-art-01a11ccadcda4d4dbd6d640f55cec81a2024-12-11T21:20:12ZengBMJ Publishing GroupBMJ Global Health2059-79082020-03-015310.1136/bmjgh-2019-002073Ending TB in Southeast Asia: current resources are not enoughVineet Bhatia0Rahul Srivastava1K Srikanth Reddy2Mukta Sharma3Partha Pratim Mandal4Natasha Chhabra5Shubhi Jhalani6Sandip Mandal7Nimalan Arinaminpathy8Tjandra Yoga Aditama9Swarup Sarkar10Department of Communicable Diseases, World Health Organization Regional Office for South-East Asia, New Delhi, IndiaDepartment of Communicable Diseases, World Health Organization Regional Office for South-East Asia, New Delhi, IndiaBruyere Research Institute, Ottawa, Ontario, CanadaDepartment of Communicable Diseases, World Health Organization Regional Office for South-East Asia, New Delhi, IndiaDepartment of Communicable Diseases, World Health Organization Regional Office for South-East Asia, New Delhi, IndiaDepartment of Sociology, University of Maryland Baltimore, Baltimore, Maryland, USAKnowledge Centre, Indian Institute of Management Shillong, Shillong, IndiaDivision of Epidemiology and Communicable Diseases (Clinical Studies, Projection & Policy Unit), Indian Council of Medical Research, New Delhi, IndiaImperial College London School of Public Health, London, UKDepartment of Communicable Diseases, World Health Organization Regional Office for South-East Asia, New Delhi, IndiaDepartment of Health Research, Indian Council of Medical Research, New Delhi, IndiaThe Southeast Asia Region continues to battle tuberculosis (TB) as one of its most severe health and development challenges. Unless there is a substantial increase in investments for TB prevention, diagnosis, care and treatment, there will be catastrophic effects for the region. The uncontrolled TB burden impacts socioeconomic development and increase of drug resistance in the region. Based on epidemiological inputs from a mathematical model, a costing analysis estimates that the desired targets of ending TB are achievable with additional interventions, and critical thresholds require an increase in spending by almost double the current levels. The data source for financial allocation to TB programmes is the report submitted by countries to WHO, while projections are based on modelling. The model accounts for funding needs for all strategies based on published data and accounts for programme and patient costs. This paper delineates the resource needs, availability and gaps of ending TB in the region. It is estimated that close to US$2 billion per year are needed in the region for TB-related activities for a meaningful bending of the incidence curve towards ending TB.https://gh.bmj.com/content/5/3/e002073.full |
| spellingShingle | Vineet Bhatia Rahul Srivastava K Srikanth Reddy Mukta Sharma Partha Pratim Mandal Natasha Chhabra Shubhi Jhalani Sandip Mandal Nimalan Arinaminpathy Tjandra Yoga Aditama Swarup Sarkar Ending TB in Southeast Asia: current resources are not enough BMJ Global Health |
| title | Ending TB in Southeast Asia: current resources are not enough |
| title_full | Ending TB in Southeast Asia: current resources are not enough |
| title_fullStr | Ending TB in Southeast Asia: current resources are not enough |
| title_full_unstemmed | Ending TB in Southeast Asia: current resources are not enough |
| title_short | Ending TB in Southeast Asia: current resources are not enough |
| title_sort | ending tb in southeast asia current resources are not enough |
| url | https://gh.bmj.com/content/5/3/e002073.full |
| work_keys_str_mv | AT vineetbhatia endingtbinsoutheastasiacurrentresourcesarenotenough AT rahulsrivastava endingtbinsoutheastasiacurrentresourcesarenotenough AT ksrikanthreddy endingtbinsoutheastasiacurrentresourcesarenotenough AT muktasharma endingtbinsoutheastasiacurrentresourcesarenotenough AT parthapratimmandal endingtbinsoutheastasiacurrentresourcesarenotenough AT natashachhabra endingtbinsoutheastasiacurrentresourcesarenotenough AT shubhijhalani endingtbinsoutheastasiacurrentresourcesarenotenough AT sandipmandal endingtbinsoutheastasiacurrentresourcesarenotenough AT nimalanarinaminpathy endingtbinsoutheastasiacurrentresourcesarenotenough AT tjandrayogaaditama endingtbinsoutheastasiacurrentresourcesarenotenough AT swarupsarkar endingtbinsoutheastasiacurrentresourcesarenotenough |